Loss of Homeostasis in the Direct Pathway in a Mouse Model of Asymptomatic Parkinson's Disease

被引:40
|
作者
Escande, Mariela V. [1 ,2 ]
Taravini, Irene R. E. [3 ,4 ,5 ]
Zold, Camila L. [1 ,2 ]
Belforte, Juan E. [1 ,2 ]
Gustavo Murer, M. [1 ,2 ]
机构
[1] Consejo Nacl Invest Cient & Tecn, IFIBIO Bernardo Houssay, Syst Neurosci Grp, RA-1121 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Med, Dept Physiol & Biophys, RA-1121 Buenos Aires, DF, Argentina
[3] Consejo Nacl Invest Cient & Tecn, ININFA, Expt Parkinsonism Grp, RA-1121 Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, RA-1121 Buenos Aires, DF, Argentina
[5] Univ Entre Rios, Expt Neurobiol Lab, RA-2820 Concepcion Del Uruguay, Entre Rios, Argentina
来源
JOURNAL OF NEUROSCIENCE | 2016年 / 36卷 / 21期
关键词
6-OHDA; functional connectivity; in vivo electrophysiology; medium spiny neurons; striatum; STRIATAL PROJECTION NEURONS; MEDIUM SPINY NEURONS; EXTERNAL GLOBUS-PALLIDUS; BAC TRANSGENIC MICE; BASAL GANGLIA; IN-VIVO; STRIATOPALLIDAL NEURONS; L-DOPA; FEEDFORWARD INHIBITION; NIGROSTRIATAL DAMAGE;
D O I
10.1523/JNEUROSCI.0492-15.2016
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The characteristic slowness of movement in Parkinson's disease relates to an imbalance in the activity of striatal medium spiny neurons (MSNs) of the direct (dMSNs) and indirect (iMSNs) pathways. However, it is still unclear whether this imbalance emerges during the asymptomatic phase of the disease or if it correlates with symptom severity. Here, we have used in vivo juxtacellular recordings and transgenic mice showing MSN-type-specific expression of fluorescent proteins to examine striatal imbalance after lesioning dopaminergic neurons of the substantia nigra. Multivariate clustering analysis of behavioral data discriminated 2 groups of dopamine-lesioned mice: asymptomatic (42 +/- 7% dopaminergic neuron loss) and symptomatic (85 +/- 5% cell loss). Contrary to the view that both pathways have similar gain in control conditions, dMSNs respond more intensely than iMSNs to cortical inputs in control animals. Importantly, asymptomatic mice show significant functional disconnection of dMSNs from motor cortex without changes in iMSN connectivity. Moreover, not only the gain but also the timing of the pathways is altered in symptomatic parkinsonism, where iMSNs fire significantly more and earlier than dMSNs. Therefore, cortical drive to dMSNs decreases after partial nigrostriatal lesions producing no behavioral impairment, but additional alterations in the gain and timing of iMSNs characterize symptomatic rodent parkinsonism.
引用
收藏
页码:5686 / 5698
页数:13
相关论文
共 50 条
  • [31] Reconstruction of the nigrostriatal pathway in a rat model of Parkinson's disease
    Ziemba, Kristine
    Jin, Ying
    Yurek, David
    Smith, George
    JOURNAL OF NEUROTRAUMA, 2007, 24 (07) : 1270 - 1270
  • [32] Progressive neurodegeneration in a new mouse model of Parkinson's disease
    Totterdell, S
    Lau, YS
    Petroske, E
    Callen, S
    Meredith, GE
    BASAL GANGLIA VII, 2002, 52 : 465 - 474
  • [33] Exposure to bifenthrin contributes to Parkinson's disease in mouse model
    Han, C.
    Liu, S.
    Huang, J.
    Liu, L.
    Ma, K.
    Guo, X.
    Guo, S.
    Wang, L.
    Shen, Y.
    Xia, Y.
    Wan, F.
    Xiong, N.
    Wang, T.
    MOVEMENT DISORDERS, 2017, 32
  • [34] Gut bacterial composition in a mouse model of Parkinson's disease
    Perez-Pardo, P.
    Dodiya, H. B.
    Engen, P. A.
    Naqib, A.
    Forsyth, C. B.
    Green, S. J.
    Garssen, J.
    Keshavarzian, A.
    Kraneveld, A. D.
    BENEFICIAL MICROBES, 2018, 9 (05) : 799 - 814
  • [35] Evaluating retinal biomarkers in a mouse model of Parkinson's disease
    Nguyen, Christine Tram Oanh
    Tran, Katie
    Lim, Jeremiah Kah Heng
    Wong, Vickie Hoi Ying
    Shahandeh, Ali
    Vingrys, Algis J.
    Bui, Bang V.
    Finkelstein, David
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [36] Altered Thalamocortical Signaling in a Mouse Model of Parkinson's Disease
    Swanson, Olivia K.
    Yevoo, Priscilla E.
    Richard, Dave
    Maffei, Arianna
    JOURNAL OF NEUROSCIENCE, 2023, 43 (34): : 6021 - 6034
  • [37] PARKIN GENE THERAPY IN A MOUSE MODEL OF PARKINSON'S DISEASE
    Yasuda, Toru
    Nihira, Tomoko
    Hayakawa, Hideki
    Ren, Yong-Ri
    Hattori, Nobutaka
    Mizuno, Yoshikuni
    Mochizuki, Hideki
    JOURNAL OF GENE MEDICINE, 2009, 11 (12): : 1174 - 1174
  • [38] Rotigotine prevents neurodegeneration in a mouse model of Parkinson's disease
    Stichel, C. C.
    Scheller, D. K. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 108 - 108
  • [39] Evaluation of gastrointestinal function in a mouse model of Parkinson's disease
    Anderson, G.
    Taylor, G.
    Bernhard, D.
    Anitha, M.
    Srinivasan, S.
    Greene, J. G.
    MOVEMENT DISORDERS, 2007, 22 : S18 - S18
  • [40] Apigenin alleviates neuroinflammation in a mouse model of Parkinson's disease
    Yarim, Gul Fatma
    Kazak, Filiz
    Yarim, Murat
    Sozmen, Mahmut
    Genc, Bugra
    Ertekin, Ali
    Gokceoglu, Ayris
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2022,